bosentan anhydrous has been researched along with Ovarian Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayir, Y; Ferah, I; Halici, Z; Keles, ON; Kilic, N; Polat, B; Sengul, O; Yilmaz, M | 1 |
1 other study(ies) available for bosentan anhydrous and Ovarian Diseases
| Article | Year |
|---|---|
Blockade of endothelin receptors with bosentan limits ischaemia/reperfusion-induced injury in rat ovaries.
Topics: Animals; Bosentan; Endothelin Receptor Antagonists; Female; Ovarian Diseases; Ovary; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Receptors, Endothelin; Reperfusion Injury; Sulfonamides | 2013 |